ATLANTA, GA , an emerging conglomerate in the flourishing Health and Cosmeceutical industry, has approved the launch of a repurchase shares program of its common stock via open market purchases throughout fiscal 2008 as the Company deems appropriate.

Our intention is to continuously enhance shareholder value through the buyback program by reducing the number of shares held by the public with each opportunistic acquisition of our highly undervalued security. "We find no better investment for our leftover retained profits than our own company," stated CEO Paul Smith.

In a combination effort to protect and enhance shareholder value, the Company has elected to not pursue any 504 Regulation D offerings to supply its operating capital. "We feel the two initiatives reflect our overwhelming confidence in Medspas' future. All the pieces are in place with our advanced business model, demographics and trendline to make Natural Renu a major revenue producer for the Company. We believe that superior execution, strict financial discipline and prudent capital deployment are the true keys to our overall success," stated CEO Paul Smith.

About Natural Renu

The company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu. The company's new initiative is a line of cosmeceutical products focusing on the anti-aging and skin healthcare markets. The company sales efforts are focused primarily through two marketing channels. The first and primary sales channel is Internet Retailing. The second target audience is to exclusive Plastic Surgeons and Dermatology practices, Day spas, Resorts and Medspas around the world.

SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbour provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.

Investor Contact Information: Paul Smith Investor Relations 1-866-595-1081 Email Contact